EFSA reasoned opinions on the modification of the existing MRLs for tebuconazole and indoxacarb
Sign in to continue
Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access